Biora Therapeutics, Inc. (BIORQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jun 2, 2026, 9:30 AM EST
Biora Therapeutics Market Cap
Biora Therapeutics has a market cap or net worth of $442 as of June 8, 2026. Its market cap has decreased by -100.00% in one year.
Market Cap
442.00
Enterprise Value
n/a
Revenue
892.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 19, 2020, Biora Therapeutics's market cap has decreased from 592.55M to 442.00, a decrease of -100.00%. That is a compound annual growth rate of -90.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 442.00 | 10,950.00% |
| Dec 31, 2025 | 4.00 | -100.00% |
| Dec 31, 2024 | 818.27K | -97.77% |
| Dec 29, 2023 | 36.73M | 24.98% |
| Dec 30, 2022 | 29.39M | -92.14% |
| Dec 31, 2021 | 373.79M | 26.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alzex Neuropharma | 753.00 |
| Pathfinder Cell Therapy | 667.00 |
| U.S. Stem Cell | 662.00 |
| Proteonomix | 633.00 |
| Amarantus BioScience Holdings | 630.00 |
| Tetra Bio-Pharma | 516.00 |
| Virpax Pharmaceuticals | 497.00 |
| Nabriva Therapeutics | 323.00 |